Wells Fargo’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Wells Fargo’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-180	Closed	–	–	6735
2015 Q3	$0	Sell	180 -540	-75%	-$601	﹤0.01%	6812
2015 Q2	$1K	Sell	720 -368	-34%	-$876	﹤0.01%	6304
2015 Q1	$3K	Sell	1,088 -320	-23%	-$1.26K	﹤0.01%	5954
2014 Q4	$6K	Sell	1,408 -2,160	-61%	-$11.4K	﹤0.01%	5838
2014 Q3	$25K	Sell	3,568 -5,090	-59%	-$50.3K	﹤0.01%	5216
2014 Q2	$128K	Buy	+8,658	New	+$150K	﹤0.01%	4587

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Wells Fargo's RCPI Position: Q4 2015 in Review

Wells Fargo sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 180 shares.

Wells Fargo first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $128K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Wells Fargo reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Wells Fargo sold 180 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
Wells Fargo first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Wells Fargo's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $128K in Q2 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Wells Fargo's 13F filing for Q4 2015, filed 9 Feb 2016.